The Tech for Longevity event is set to take place on November 20, 2024, at Station F in Paris, gathering experts from various fields including science, healthcare, and technology.

This year's conference will spotlight advancements in AI-driven personalized medicine, cellular reprogramming, and other biotech innovations, underscoring Paris's emerging significance in the longevity sector.

A key goal of the event is to foster interdisciplinary collaboration across technology, healthcare, and wellness sectors, with a strong emphasis on practical applications of research.

Preventive health strategies aimed at the early detection of age-related diseases will be a major focus, reflecting a commitment to extending healthspan rather than merely lifespan.

Attendees can expect to see showcases of biotech advancements, particularly in gene therapies and cellular rejuvenation techniques designed to reverse cellular aging.

Key sessions will delve into the societal impacts of life extension, explore insights into the burgeoning $600 billion longevity market, and discuss the role of AI in managing aging.

The conference will also tackle ethical issues surrounding longevity, particularly the equitable access to longevity technologies and the importance of inclusivity in their implementation.

Discussions will emphasize the need for ethical considerations in the deployment of longevity technologies to ensure they benefit a broad spectrum of society.

Olivier highlights that AI can revolutionize healthcare delivery by offering personalized health interventions based on individual genetic and lifestyle data.

Henri-Nicolas Olivier, CEO of Maison Epigenetic, underscores the vital role of Paris's scientific community and tech ecosystem in driving innovation in the longevity field.

Looking ahead, Olivier plans to scale the event, with the next edition already scheduled for September 25-27, 2025, at the Grand Palais in Paris.